Norgine
Tracked across 8 events · 52 articles · First seen Apr 07, 2026 · Last active Sep 08, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Norgine received TGA registration for PEDMARQSI in Australia, expanding its market reach for this specialized medicine.
May 05, 2026 · 6 articles
Business
Impact: Norgine is Fennec's licensing partner for PEDMARQSI commercialization in Europe, U.K., Australia, and New Zealand. The event does not directly impact Norgine, but its partnership is part of Fennec's business update.
Aug 05, 2026 · 6 articles
Business
Impact: Norgine has an exclusive licensing agreement with Fennec Pharmaceuticals to commercialize PEDMARQSI in Europe, U.K., Australia, and New Zealand.
May 07, 2026 · 6 articles
Business
Impact: Norgine is the exclusive licensing partner for Fennec Pharmaceuticals' product PEDMARQSI in Europe, the UK, Australia, and New Zealand, contributing to the global commercialization of the drug.
May 14, 2026 · 6 articles
Business
Impact: Norgine has an exclusive licensing agreement with Fennec Pharmaceuticals to commercialize PEDMARQSI (PEDMARK) in Europe, U.K., Australia, and New Zealand.
Apr 07, 2026 · 7 articles
Business
Impact: Norgine is mentioned as a commercialization partner for PEDMARQSI, providing context on Fennec Pharmaceuticals' broader business activities, though not directly impacted by this specific stock option grant.
May 18, 2026 · 7 articles
Business
Impact: Norgine is mentioned as a partner commercializing PEDMARQSI in Europe, U.K., Australia, and New Zealand, indicating Fennec Pharmaceuticals' broader market strategy.
Jun 15, 2026 · 7 articles
Regulatory
X4 Pharmaceuticals announced a positive outcome from its Type C meeting with the United States — Food and Drug Administration regarding the global 4WARD Phase 3 clinical trial for mavorixafor in chronic neutropenia. The FDA…
Impact: Norgine is mentioned as a partner for commercialization of XOLREMDI in the European Union. The event does not directly affect Norgine, but a successful 4WARD trial could indirectly benefit its partnership with X4.
Sep 08, 2026 · 7 articles
ERGEN INTELLIGENCE
Track Norgine live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard